These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27582036)

  • 1. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
    Singh S; Hämäläinen RH
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unverricht-Lundborg disease: homozygosity for a new splicing mutation in the cystatin B gene.
    Pinto E; Freitas J; Duarte AJ; Ribeiro I; Ribeiro D; Lima JL; Chaves J; Amaral O
    Epilepsy Res; 2012 Mar; 99(1-2):187-90. PubMed ID: 22154554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.
    Körber I; Katayama S; Einarsdottir E; Krjutškov K; Hakala P; Kere J; Lehesjoki AE; Joensuu T
    PLoS One; 2016; 11(6):e0158195. PubMed ID: 27355630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.
    Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
    Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
    Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1.
    Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1.
    Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE
    Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.
    Assenza G; Benvenga A; Gennaro E; Tombini M; Campana C; Assenza F; Di Pino G; Di Lazzaro V
    Epilepsia; 2017 Feb; 58(2):e31-e35. PubMed ID: 27888502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study.
    Bosak M; Sułek A; Łukasik M; Żak A; Słowik A; Lasek-Bal A
    Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
    Vaarmann A; Kaasik A; Zharkovsky A
    Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative myoclonus causes locomotory disability in progressive myoclonus epilepsy type EPM1- Unverricht-Lundborg disease.
    Vogt H; Baisch T; Mueller-Pfeiffer C; Mothersill IW
    Epileptic Disord; 2023 Jun; 25(3):297-308. PubMed ID: 37536959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular characterization of Unverricht-Lundborg disease among Egyptian patients.
    Hosny H; El Tamawy M; Gouider R; Lesca G; Abdel Naseer M; Kishk N; Abdel-Hamid MS; Ashmawi A
    Epilepsy Res; 2021 Oct; 176():106746. PubMed ID: 34474241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.